tiprankstipranks
Cyclerion Therapeutics,Inc. (CYCN)
NASDAQ:CYCN
US Market
CYCN
Cyclerion Therapeutics
RESEARCH TOOLSreports
Want to see CYCN full AI Analyst Report?

Cyclerion Therapeutics (CYCN) Income Statement

266 Followers

Cyclerion Therapeutics Income Statement

Last quarter (Q4 2025), Cyclerion Therapeutics's total revenue was $1.02M, a decrease of -43.24% from the same quarter last year. In Q4, Cyclerion Therapeutics's net income was $-799.00K. See Cyclerion Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.07M$ 2.00M$ 0.00$ 297.00K$ 3.32M
Gross Profit
$ 2.07M$ 2.00M$ 0.00$ -5.28M$ 3.32M
Operating Expenses
$ 7.05M$ 5.63M$ 12.95M$ 13.26M$ 58.52M
Depreciation and Amortization
$ 0.00$ 0.00$ 65.00K$ 65.00K$ 472.00K
EBITDA
$ -4.97M$ -3.63M$ -9.58M$ -18.48M$ -53.84M
Operating Income
$ -4.97M$ -3.63M$ -12.95M$ -18.54M$ -55.20M
Other Income/Expenses
$ 1.45M$ 571.00K$ 358.00K$ 294.00K$ 3.55M
Pretax Income
$ -3.53M$ -3.06M$ -12.59M$ -18.25M$ -51.65M
Net Income
$ -3.53M$ -3.06M$ -5.26M$ -44.08M$ -51.65M
Per Share Metrics
Basic EPS
$ -1.09$ -1.21$ -8.99$ -20.15$ -26.40
Diluted EPS
$ -1.09$ -1.21$ -8.99$ -20.15$ -26.40
Weighted Average Shares Outstanding
 3.23M 2.52M 2.34M 2.17M 1.96M
Weighted Average Shares Outstanding (Diluted)
 3.23M 2.52M 2.34M 2.17M 1.96M
Currency in USD

Cyclerion Therapeutics Earnings and Revenue History